Mary 
is the Executive Director for the Castleman Disease Collaborative Network (CDCN) and currently works for Vanguard in Malvern, PA. She is passionate about applying innovative solutions to find treatments for rare disease patients, and curing Castleman disease. Mary has over ten years of leadership experience across disciplines of Strategy, IT, HR, Marketing, Finance, and client success across various business lines in financial services.
Mary graduated from Pennsylvania State University, where she received a BS and MBA. Mary began as a volunteer with the CDCN in 2014.